0001628280-26-028849
SEC filingNutex Health's Notes show $207.3M cash, $31.7M buybacks, and hospital gross profit drop; $2.7M accrued stock compensation liability.
As of March 31, 2026, Nutex Health held $207.3 million in cash and cash equivalents, along with $3.3 million in restricted cash, totaling $210.6 million. Total assets amounted to $957.3 million, while total liabilities were $515.3 million. Shareholders' equity (Nutex Health Inc. equity) stood at $346.3 million, with noncontrolling interests of $95.8 million. The company has $41.3 million in total debt (including lines of credit) and $24.3 million in long-term debt, net. Operating cash flow for the quarter was $75.5 million.
Note 10 (Commitments and Contingencies) discloses no material litigation accruals, and no specific purchase commitments are reported beyond normal operating obligations. The company does disclose $56.8 million in accrued arbitration expenses related to out-of-network reimbursement disputes, but these are not contractual purchase commitments.
During Q1 2026, Nutex repurchased and retired 200,444 shares of common stock for $31.7 million, including $22.0 million under two board-authorized repurchase programs and $9.7 million via settlement agreements. A new $25.0 million repurchase program was authorized on March 4, 2026, with $23.0 million remaining as of quarter-end. No dividends were declared. Net debt decreased by $2.1 million, primarily due to repayments. Capital expenditures were $1.2 million in cash, with an additional $1.7 million in financed leases (non-cash investing).
Nutex reports three segments: hospital division, population health management (PHM) division, and real estate division. External revenue for Q1 2026: hospital $207.6 million (up 1.8% YoY), PHM $8.9 million (up 13.7% YoY). Segment gross profit (operating income before corporate costs) was $89.6 million for hospital (43.2% margin), $2.4 million for PHM (27.0% margin), and a loss of $0.3 million for real estate (no external revenue). The hospital division's gross profit declined significantly from $117.9 million in Q1 2025, driven by higher contract services and payroll costs. No geographic segment data is disclosed.